PROCEPT BioRobotics (PRCT) Leases (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Leases data on file, last reported at $17.2 million in Q1 2026.

• Quarterly Leases fell 7.76% year-over-year to $17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.2 million (down 7.76% YoY) and the FY2025 annual result came in at $17.5 million, down 7.41% from the prior year.
• Leases retreated to $17.2 million in Q1 2026 per PRCT's latest filing, from $17.5 million in the prior quarter.
• Across five years, Leases topped out at $24.4 million in Q3 2022 and bottomed at $2.5 million in Q2 2022.
• The 5-year median for Leases is $19.3 million (2024), against an average of $17.9 million.
• Peak annual rise in Leases reached 775.48% in 2023, while the deepest fall reached 15.25% in 2023.
• Tracing PRCT's Leases over 5 years: stood at $22.7 million in 2022, then retreated by 10.83% to $20.2 million in 2023, then decreased by 6.42% to $18.9 million in 2024, then decreased by 7.41% to $17.5 million in 2025, then declined by 2.14% to $17.2 million in 2026.
• Per Business Quant, the three latest PRCT Leases figures stand at $17.2 million (Q1 2026), $17.5 million (Q4 2025), and $17.9 million (Q3 2025).

Peer Comparison